Market Overview

On Monday 26 November 2026, Yunnan Baiyao Group Co. Ltd. (000538.SZ) closed the trading session unchanged, maintaining a flat 0 % change over the 24‑hour period that concluded at 12:16 PM Central Europe. The stock trades at approximately CNY 53.61 on the Shenzhen Stock Exchange, with a current supply of 1.8 billion shares. At this level the company’s market capitalisation stands at roughly CNY 93.5 billion, and the total volume of shares exchanged in the last 24 hours amounts to about CNY 565.3 million.

Since the close of the previous month, Yunnan Baiyao has risen by 5.07 %. Its 200‑day simple moving average rests at CNY 50.42, indicating a relatively stable trend. The most recent 52‑week high was CNY 58.20 (02 June 2026) and the low was CNY 46.29 (29 June 2026), suggesting that the current price sits comfortably within the recent high‑low range.

Peer Performance in the Past 24 Hours

  • Gf Securities –H (1776.HK) The brokerage listed in Hong Kong moved up 2.68 % to HKD 15.91. With a market capitalisation of HKD 125.7 billion and a price‑to‑earnings ratio of 6.02, the firm is gaining attention for its role as a joint sponsor in the high‑profile listing of Suzhou Dongshan Precision Manufacturing Co. The IPO raised nearly HK$10 billion, backed by cornerstone investors including JPMorgan, Alibaba, and Guotai Haitong. Recent third‑quarter earnings demonstrate steady revenue growth, healthy profit margins, and a dividend policy aligned with the broader market’s increasing focus on shareholder returns.

  • China Coal Energy –H (1898.HK) The coal producer edged up 0.48 % to HKD 9.61. Its market capitalisation is HKD 125.4 billion, with a price‑to‑earnings ratio of 7.18.

  • Zangge Mining (000408.SZ) The lithium‑related miner traded flat at CNY 68.99. With a market capitalisation of CNY 107.9 billion and a price‑to‑earnings ratio of 15.01, the company reported first‑quarter earnings for the 2026 fiscal year that show a noticeable rise in net profit versus the same period last year. Production of lithium carbonate equivalent increased, largely due to the partnership with Zangge Mining, and higher average sales prices for lithium products contributed to the profit growth. The company’s lithium assets, including a significant Australian hard‑rock mine and a Sichuan domestic project, are progressing toward higher production capacity.

  • Shenzhen Longsys Electronics (301308.SZ) The semiconductor firm traded flat at CNY 232.83, with a market capitalisation of CNY 108.9 billion and a price‑to‑earnings ratio of 13.42. Recent analyst coverage highlights a sector‑wide reassessment, suggesting that several memory‑chip names may be undervalued. Shares opened lower but recovered during the session, reflecting broader industry volatility. Investor activity in the electronics segment remains mixed, with net selling flows, although some names attracted net buying interest. No immediate strategic developments were reported, but upcoming quarterly releases and policy updates may influence sentiment.

  • Accelink (002281.SZ) The optical‑module manufacturer traded flat at CNY 122.53, with a market capitalisation of CNY 106.5 billion and a price‑to‑earnings ratio of 85.37. Accelink’s third‑quarter results show robust growth in revenue and earnings, attributed to increased demand for high‑speed optical modules driven by global artificial‑intelligence infrastructure spending and domestic cloud‑service expansion. A strong order backlog and ongoing development of next‑generation optical interconnect technologies reinforce the company’s position in the AI and data‑center markets. The national social‑security fund and a major investment firm increased their holdings following the results, signalling confidence in Accelink’s trajectory.

Company Profile – Yunnan Baiyao

Yunnan Baiyao Group Co. Ltd. is a health‑care company operating within the pharmaceuticals sector. Headquartered in Kunming, China, the company is listed on the Shenzhen Stock Exchange. Founded on 6 November 1993, Yunnan Baiyao produces a diversified portfolio that includes chemical raw medicines, chemical preparations, proprietary Chinese medicines, Chinese herbal medicines, and related products. The firm also manufactures medical equipment. Further information on its product range and corporate initiatives can be found on its official website: www.yunnanbaiyao.com.cn .